VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced vulvar cancer: triple therapy shows promise
Disease control OngoingThis study tests a combination of standard chemotherapy (cisplatin), an immunotherapy drug (pembrolizumab), and radiation therapy for people with vulvar cancer that cannot be removed by surgery. The goal is to see if this triple therapy can shrink or control the cancer better tha…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 05:59 UTC
-
Cancer-killing virus plus immune booster shows promise for rare skin tumors
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't responded to standard care. First, patients receive a virus-based therapy (talimogene laherparepvec) that infects and kills tumor cells. Then, they also get an immunotherapy …
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC